Management raised full-year sales guidance to a low 20% increase over last year, citing robust first-half sales and the integration of Nissens. Adjusted EBITDA margin guidance was reaffirmed at 10% to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback